High Incidence of Triple-Negative Tumors in Sub-Saharan Africa: A Prospective Study of Breast Cancer Characteristics and Risk Factors in Malian Women Seen in a Bamako University Hospital
Authors:
- Madani LyMadani Ly
- Martine AntoineMAMartine Antoine
- Abdoul Karim DembéléADAbdoul Karim Dembélé
- Pierre LevyPierre Levy
- Anita RodenasARAnita Rodenas
- Boubacari Ali TouréBTBoubacari Ali Touré
- Youssouf BadiagaYBYoussouf Badiaga
- Bakary Kossa DembéléBDBakary Kossa Dembélé
- Djénèba Coulibaly BagayogoDBDjénèba Coulibaly Bagayogo
- Yacouba Lazare DialloYDYacouba Lazare Diallo
- Abdramane A. KonéAKAbdramane A. Koné
- Patrice CallardPCPatrice Callard
Open Access
- 1 September 2012
- journal article
- reducing the-worldwide-burden-of-cancer
- Published by S. Karger AG in Oncology
- Vol. 83 (5) , 257-263
Abstract
Objective: Few studies have been conducted on breast cancer in Sub-Saharan Africa and their results have been suspected to be impaired by artefacts. This prospective study was designed to determine tumor and patient characteristics in Mali with control of each methodological step. These data are necessary to define breast cancer treatment guidelines in this country. Methods: Clinical and tumor characteristics and known risk factors were obtained in a consecutive series of 114 patients. Each technical step for the determination of tumor characteristics [histology, TNM, grade, estrogen (ER) and progesterone receptors (PR), HER2, and Ki67] was controlled. Results: Patients had a mean age of 46 years. Most tumors were invasive ductal carcinomas (94%), T3-T4 (90%) with positive nodes (91%), grade III (78%), and ER (61%) and PR (72%) negative. HER2 was overexpressed in 18% of cases. The triple-negative subgroup represented 46%, displaying a particularly aggressive pattern (90% grade III; 88% Ki67 >20%). Conclusion: This study demonstrates the high incidence of aggressive triple-negative tumors in Mali. Apart from a higher prevalence of premenopausal women, no significant difference in risk factors was observed between triple-negative tumors and other tumors. The hormonal therapy systematically prescribed therefore needs to be revised in light of this study.Keywords
This publication has 31 references indexed in Scilit:
- Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosisBreast Cancer Research, 2011
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast CancerNew England Journal of Medicine, 2011
- Emerging breast cancer epidemic: evidence from AfricaBreast Cancer Research, 2010
- Triple negative breast cancer: unmet medical needsBreast Cancer Research and Treatment, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 YearsCancer Epidemiology, Biomarkers & Prevention, 2009
- Immunohistochemical and molecular subtypes of breast cancer in NigeriaBreast Cancer Research and Treatment, 2007
- Epidemiology of basal-like breast cancerBreast Cancer Research and Treatment, 2007
- Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based StudyCancer Epidemiology, Biomarkers & Prevention, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006